Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) as a highly potent and conformal brachytherapy for solid tumors. Safety and efficacy of DaRT were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trials.